PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES
Summary
The European Patent Office granted Patent EP3244930A1 to the University of Southern California on April 8, 2026. The patent covers pharmaceutical compositions comprising POH derivatives for therapeutic applications including cancer treatment. The patent is designated across 38 European member states including DE, FR, GB, IT, ES, NL, BE, and others.
What changed
The European Patent Office issued Patent EP3244930A1 to the University of Southern California, inventors Chen, Levin, and Pupalli, covering pharmaceutical compositions comprising POH derivatives. The patent is designated in 38 European states including Germany, France, United Kingdom, Italy, Spain, Netherlands, Belgium, Switzerland, Austria, Poland, Sweden, Denmark, Finland, Norway, Portugal, Greece, Czech Republic, Hungary, Romania, and others.\n\nGeneric pharmaceutical manufacturers and R&D companies developing POH-based therapeutics must consider this granted patent when planning market entry strategies in European designated states. Freedom-to-operate analyses and potential licensing negotiations may be necessary before commercializing similar compounds.
What to do next
- Monitor for updates
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES
Publication EP3244930A1 Kind: A1 Apr 08, 2026
Applicants
University of Southern California
Inventors
CHEN, Thomas, LEVIN, Daniel, PUPALLI, Satish G.
IPC Classifications
A61K 31/415 20060101AFI20251120BHEP A61K 47/54 20170101ALI20251120BHEP A61K 47/55 20170101ALI20251120BHEP C07D 207/26 20060101ALI20251120BHEP A61K 31/4015 20060101ALI20251120BHEP C07D 487/04 20060101ALI20251120BHEP C07D 231/12 20060101ALI20251120BHEP A61N 5/10 20060101ALI20251120BHEP A61K 9/00 20060101ALI20251120BHEP A61K 45/06 20060101ALI20251120BHEP A61P 35/00 20060101ALI20251120BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.